These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 28625359)

  • 21. Role of ARHGAP24 in ADP Ribosylation Factor 6 (ARF6)-dependent Pseudopod Formation in Human Breast Carcinoma Cells.
    Uehara S; Saito K; Asami H; Ohta Y
    Anticancer Res; 2017 Sep; 37(9):4837-4844. PubMed ID: 28870903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NEDD9/Arf6-dependent endocytic trafficking of matrix metalloproteinase 14: a novel mechanism for blocking mesenchymal cell invasion and metastasis of breast cancer.
    Loskutov YV; Kozyulina PY; Kozyreva VK; Ice RJ; Jones BC; Roston TJ; Smolkin MB; Ivanov AV; Wysolmerski RB; Pugacheva EN
    Oncogene; 2015 Jul; 34(28):3662-75. PubMed ID: 25241893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arf6 and its ZEB1-EPB41L5 mesenchymal axis are required for both mesenchymal- and amoeboid-type invasion of cancer cells.
    Handa H; Hashimoto A; Hashimoto S; Sabe H
    Small GTPases; 2018 Sep; 9(5):420-426. PubMed ID: 27754741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GEP100/Arf6 is required for epidermal growth factor-induced ERK/Rac1 signaling and cell migration in human hepatoma HepG2 cells.
    Hu Z; Du J; Yang L; Zhu Y; Yang Y; Zheng D; Someya A; Gu L; Lu X
    PLoS One; 2012; 7(6):e38777. PubMed ID: 22701712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chlortetracycline, a Novel Arf Inhibitor That Decreases the Arf6-Dependent Invasive Properties of Breast Cancer Cells.
    Macia E; Vazquez-Rojas M; Robiolo A; Fayad R; Abélanet S; Mus-Veteau I; Fontaine-Vive F; Mehiri M; Luton F; Franco M
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33673086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fbx8 makes Arf6 refractory to function via ubiquitination.
    Yano H; Kobayashi I; Onodera Y; Luton F; Franco M; Mazaki Y; Hashimoto S; Iwai K; Ronai Z; Sabe H
    Mol Biol Cell; 2008 Mar; 19(3):822-32. PubMed ID: 18094045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A NAV2729-sensitive mechanism promotes adrenergic smooth muscle contraction and growth of stromal cells in the human prostate.
    Yu Q; Gratzke C; Wang R; Li B; Kuppermann P; Herlemann A; Tamalunas A; Wang Y; Rutz B; Ciotkowska A; Wang X; Strittmatter F; Waidelich R; Stief CG; Hennenberg M
    J Biol Chem; 2019 Aug; 294(32):12231-12249. PubMed ID: 31243101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ADP-ribosylation factor 6 regulates tumorigenic and invasive properties in vivo.
    Muralidharan-Chari V; Hoover H; Clancy J; Schweitzer J; Suckow MA; Schroeder V; Castellino FJ; Schorey JS; D'Souza-Schorey C
    Cancer Res; 2009 Mar; 69(6):2201-9. PubMed ID: 19276388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arf6 regulates RhoB subcellular localization to control cancer cell invasion.
    Zaoui K; Rajadurai CV; Duhamel S; Park M
    J Cell Biol; 2019 Nov; 218(11):3812-3826. PubMed ID: 31591185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ADP Ribosylation Factor 6 Promotes Contraction and Proliferation, Suppresses Apoptosis and Is Specifically Inhibited by NAV2729 in Prostate Stromal Cells.
    Wang R; Schneider S; Keppler OT; Li B; Rutz B; Ciotkowska A; Stief CG; Hennenberg M
    Mol Pharmacol; 2021 Oct; 100(4):356-371. PubMed ID: 34349027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The EFA6 family: guanine nucleotide exchange factors for ADP ribosylation factor 6 at neuronal synapses.
    Sakagami H
    Tohoku J Exp Med; 2008 Mar; 214(3):191-8. PubMed ID: 18323689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Class I Arfs (Arf1 and Arf3) and Arf6 are localized to the Flemming body and play important roles in cytokinesis.
    Hanai A; Ohgi M; Yagi C; Ueda T; Shin HW; Nakayama K
    J Biochem; 2016 Feb; 159(2):201-8. PubMed ID: 26330566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation machinery of the small GTPase Arf6.
    Hongu T; Kanaho Y
    Adv Biol Regul; 2014 Jan; 54():59-66. PubMed ID: 24139303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EFA6A enhances glioma cell invasion through ADP ribosylation factor 6/extracellular signal-regulated kinase signaling.
    Li M; Ng SS; Wang J; Lai L; Leung SY; Franco M; Peng Y; He ML; Kung HF; Lin MC
    Cancer Res; 2006 Feb; 66(3):1583-90. PubMed ID: 16452216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ARF6, PI3-kinase and host cell actin cytoskeleton in Toxoplasma gondii cell invasion.
    da Silva CV; da Silva EA; Cruz MC; Chavrier P; Mortara RA
    Biochem Biophys Res Commun; 2009 Jan; 378(3):656-61. PubMed ID: 19061866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ADP-ribosylation factor 6 regulates mu-opioid receptor trafficking and signaling via activation of phospholipase D2.
    Rankovic M; Jacob L; Rankovic V; Brandenburg LO; Schröder H; Höllt V; Koch T
    Cell Signal; 2009 Dec; 21(12):1784-93. PubMed ID: 19666113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The small GTPase ARF6 regulates GABAergic synapse development.
    Kim H; Jung H; Jung H; Kwon SK; Ko J; Um JW
    Mol Brain; 2020 Jan; 13(1):2. PubMed ID: 31907062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endothelin-1 promotes migration of endothelial cells through the activation of ARF6 and the regulation of FAK activity.
    Daher Z; Noël J; Claing A
    Cell Signal; 2008 Dec; 20(12):2256-65. PubMed ID: 18814847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The EGFR-GEP100-Arf6 pathway in breast cancer: Full invasiveness is not from the inside.
    Sabe H; Hashimoto S; Morishige M; Hashimoto A; Ogawa E
    Cell Adh Migr; 2008; 2(2):71-3. PubMed ID: 19262097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metastasis: wherefore arf thou?
    Premont RT; Schmalzigaug R
    Curr Biol; 2009 Dec; 19(22):R1036-8. PubMed ID: 19948141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.